Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for postoperative analgesia and GI recovery after gynecologic laparoscopic surgery
ChiCTR2500110159Phase 4Not yet recruiting
- Sponsor
- Anqing Municipal Hospital
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oliceridine in postoperative pain (2 arms), sponsored by Anqing Municipal Hospital. Primary endpoints: Incidence of moderate to severe acute pain within 24 hours postoperatively and Time to first flatus postoperatively. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500110159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110159.